Global Antivenom Market Analysis, Share, Trends and Forecast by 2022

The Global Antivenom Market is expected to reach USD 1,493.2 million by 2021 from USD 1,109.5 million in 2016, growing at a CAGR of 6.12% during the forecast period 2016-2021. Antivenom is described as the biological product that detoxifies poisoning of venomous bites. Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It is estimated that, approximately 100,000 people die worldwide with snake bites annually. To overcome poisonous effects after venomous bites the global manufacturers developed number of Antivenom products including vaccines and hyperimmune sera.

Browse the report: http://www.orbisresearch.com/reports/index/antivenom-market-by-type-by-animal-and-by-region-global-industry-analysis-size-share-growth-trends-and-forecasts-2016-2021

Increasing government initiations to promote the development of high quality antivenom products, presence of highest number of snake bite victims (especially from Asia & Africa regions), and estimated pipeline products launch are driving the growth of global Antivenom Market. In addition, growing of deaths from venomous animal’s bites and increasing research to develop advanced antivenom products are further stimulating the growth of global Antivenom Market. However, withdrawal of antivenom products, Lack of regulatory capacity for control of anti-venom, high cost of the products are restraining the growth of global Antivenom Market.

The Global market for Antivenom is broadly categorized by Animal Type, Antivenom type and Hyperimmune Sera. On the basis of Antivenom type, the market is segmented into monovalent, bivalent, trivalent, tetravalent and polyvalent products. Based on animal the market is segmented into Snakes, Scorpions, Spiders, and Others. Based on Hyperimmune Sera the market is segmented as Homologous and Heterologous antivenoms.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/292977

On the basis of geography, the global market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America is the dominating market for Antivenom followed by Europe in 2016.
Key market players in the global Antivenom market include CSL Limited (Australia), BTG Plc (U.K.), Merck & Co., Inc. (U.S.), PT Bio Farma, Incepta Vaccine Ltd. (Bangladesh), Instituto Bioclon, S.A. de C.V. (Mexico), Bharat Serum and Vaccines Limited (BSV) (India), Instituto Butantan, Rare Disease Therapeutics, Inc. (U.S.) and Vins Bioproducts Limited (India).

Major Points From The Table Of Contents:
Introduction
Research Methodology
Overview
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
Market Segmentation
Geographical Analysis
Strategic Analysis
Market Leaders' Analysis
Competitive Landscape
Market Outlook and Investment Opportunities

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

This release was published on openPR.